This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Minnesota and the American Association for Cancer Research. The University of Minnesota is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Credit Designation Statement
The University of Minnesota designates this educational activity for a maximum of 51 Category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
Statement of Educational Need, Target Audience, and Learning Objectives
New technology and the resulting explosion in biological information have led to a significantly improved understanding of cancer development and progression, with major implications for cancer prevention, diagnosis, and treatment. By participating in the AACR 96th Annual Meeting, clinical investigators and physicians will better understand the contributions of laboratory research to patient care, to the design and conduct of clinical research protocols, the epidemiological implications of cancer incidence, and the translation of the findings of laboratory research immediately for the benefit and care of the cancer patient. Through this participation of clinical investigators and physicians, laboratory researchers will obtain a better understanding of the wider context of their research and of the particular clinical problems that regularly confront physicians.
Scientists and clinicians engaged in all aspects of clinical investigations pertaining to human cancer as well as the scientific disciplines of cellular and molecular biology; tumor biology; carcinogenesis; chemistry; clinical research; endocrinology; epidemiology; experimental and molecular therapeutics; immunology; and prevention research.
At the conclusion of this educational activity, each participant should be able to:
- Understand the latest research findings in all areas of cancer research;
- Understand the importance of integrating information from basic and clinical research to conquer cancer;
- Understand the epidemiological implications of cancer incidence;
- Understand how technological advances can be used to accelerate discovery; and
- Use these findings to expedite the development of detection, prevention, and treatment strategies to reduce cancer incidence and mortality.
It is the policy of University of Minnesota that the information presented at University of Minnesota-sponsored CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, University of Minnesota and the American Association for Cancer Research will provide information that speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available in the Proceedings of the American Association for Cancer Research.
Individuals wishing to receive Category 1 credit for their attendance at this conference should obtain a Documentation of Attendance and Request for Credit form from the CME booth located in the registration area. This form must be completed and returned to the CME booth located in the registration area to obtain a Certificate of Attendance.
Acknowledgment of Commercial Support
Commercial entities that provide unrestricted educational grants in support of this educational activity shall be listed within the Program.
Questions about CME?
Please contact Victoria A.M. Wolodzko, Assistant Director, Program Administration, at (215) 440-9300, ext. 136.